| Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay PJ Declerck, MC Alessi, M Verstreken, EKO Kruithof, I Juhan-Vague, ... | 690 | 1988 |
| Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). PJ Declerck, M De Mol, MC Alessi, S Baudner, EP Paques, KT Preissner, ... Journal of Biological Chemistry 263 (30), 15454-15461, 1988 | 645 | 1988 |
| Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2 MC Alessi, I Juhan-Vague, T Kooistra, PJ Declerck, D Collen Thrombosis and haemostasis 60 (06), 491-494, 1988 | 395 | 1988 |
| The pro‐or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent L Devy, S Blacher, C Grignet-Debrus, K Bajou, V Masson, RD Gerard, ... The FASEB journal 16 (2), 147-154, 2002 | 348 | 2002 |
| Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints K Adriaens, D Van Gucht, P Declerck, F Baeyens International journal of environmental research and public health 11 (11 …, 2014 | 291 | 2014 |
| Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response. I Juhan-Vague, MC Alessi, P Joly, X Thirion, P Vague, PJ Declerck, ... Arteriosclerosis: An Official Journal of the American Heart Association, Inc …, 1989 | 287 | 1989 |
| Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin C Isogai, WE Laug, H Shimada, PJ Declerck, MF Stins, DL Durden, ... Cancer research 61 (14), 5587-5594, 2001 | 235 | 2001 |
| Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1 M Eren, CA Painter, JB Atkinson, PJ Declerck, DE Vaughan Circulation 106 (4), 491-496, 2002 | 220 | 2002 |
| Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth K Bajou, C Maillard, M Jost, RH Lijnen, A Gils, P Declerck, P Carmeliet, ... Oncogene 23 (41), 6986-6990, 2004 | 204 | 2004 |
| Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. A Stockmann, S Hess, P Declerck, R Timpl, KT Preissner Journal of Biological Chemistry 268 (30), 22874-22882, 1993 | 198 | 1993 |
| Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis HC Kwaan, J Wang, K Svoboda, PJ Declerck British journal of cancer 82 (10), 1702-1708, 2000 | 194 | 2000 |
| Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator. PJ Declerck, M De Mol, DE Vaughan, D Collen Journal of Biological Chemistry 267 (17), 11693-11696, 1992 | 187 | 1992 |
| Comparison of random and oriented immobilisation of antibody fragments on mixed self-assembled monolayers K Bonroy, F Frederix, G Reekmans, E Dewolf, R De Palma, G Borghs, ... Journal of immunological methods 312 (1-2), 167-181, 2006 | 184 | 2006 |
| Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin PJ Declerck, A Gils Seminars in thrombosis and hemostasis 39 (04), 356-364, 2013 | 167 | 2013 |
| Plasminogen activator inhibitor-1 modulates adipocyte differentiation X Liang, T Kanjanabuch, SL Mao, CM Hao, YW Tang, PJ Declerck, ... American Journal of Physiology-Endocrinology and Metabolism 290 (1), E103-E113, 2006 | 164 | 2006 |
| The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo B Van De Craen, PJ Declerck, A Gils Thrombosis research 130 (4), 576-585, 2012 | 161 | 2012 |
| Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. KT Preissner, J Grulich-Henn, HJ Ehrlich, P Declerck, C Justus, D Collen, ... Journal of Biological Chemistry 265 (30), 18490-18498, 1990 | 154 | 1990 |
| Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines CM Halleux, PJ Declerck, SL Tran, R Detry, SM Brichard The Journal of Clinical Endocrinology & Metabolism 84 (11), 4097-4105, 1999 | 150 | 1999 |
| The language of biosimilars: clarification, definitions, and regulatory aspects P Declerck, R Danesi, D Petersel, I Jacobs Drugs 77, 671-677, 2017 | 148 | 2017 |
| Biologicals and biosimilars: a review of the science and its implications P Declerck GaBI-Generics and Biosimilars Initiative Journal 1 (1), 13-16, 2012 | 146 | 2012 |
